BCPC Overzicht aandelen
Balchem Corporation ontwikkelt, produceert en verkoopt hoogwaardige ingrediënten en producten voor de voedings-, voedsel-, farmaceutische, diergezondheids-, sterilisatie-, plantenvoeding- en industriële markten wereldwijd.
| Sneeuwvlok Score | |
|---|---|
| Waardering | 0/6 |
| Toekomstige groei | 1/6 |
| Prestaties in het verleden | 5/6 |
| Financiële gezondheid | 6/6 |
| Dividenden | 0/6 |
Beloningen
Risicoanalyse
Geen risico's gedetecteerd voor BCPC uit onze risicocontroles.
Community Narratives
Create a narrativeNarratives bring a range of perspectives from our community.
US$188.67
FV
9.1% undervalued intrinsic discount5.53%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
5 days ago author updated this narrative
Balchem Corporation Concurrenten
Prijsgeschiedenis en prestaties
| Historische aandelenkoersen | |
|---|---|
| Huidige aandelenkoers | US$171.46 |
| 52 Week Hoogtepunt | US$186.03 |
| 52 Week Laag | US$116.84 |
| Bèta | 0.64 |
| 11 maand verandering | -0.46% |
| 3 maanden verandering | 3.81% |
| 1 Jaar Verandering | 41.85% |
| 33 jaar verandering | 4.61% |
| 5 jaar verandering | 66.16% |
| Verandering sinds IPO | 68,427.53% |
Recent nieuws en updates
Balchem's Q3 Shows Record Earnings And Valuation Pressure
Oct 28Here's What To Make Of Balchem's (NASDAQ:BCPC) Decelerating Rates Of Return
Oct 21
Estimating The Fair Value Of Balchem Corporation (NASDAQ:BCPC)
Oct 07Recent updates
Balchem's Q3 Shows Record Earnings And Valuation Pressure
Oct 28Here's What To Make Of Balchem's (NASDAQ:BCPC) Decelerating Rates Of Return
Oct 21Estimating The Fair Value Of Balchem Corporation (NASDAQ:BCPC)
Oct 07Is Balchem (NASDAQ:BCPC) Using Too Much Debt?
Sep 09Here's Why We Think Balchem (NASDAQ:BCPC) Might Deserve Your Attention Today
Aug 27Balchem Corporation's (NASDAQ:BCPC) Shares May Have Run Too Fast Too Soon
Aug 13Earnings Update: Here's Why Analysts Just Lifted Their Balchem Corporation (NASDAQ:BCPC) Price Target To US$184
Jul 31Return Trends At Balchem (NASDAQ:BCPC) Aren't Appealing
Jun 29Shareholders Will Most Likely Find Balchem Corporation's (NASDAQ:BCPC) CEO Compensation Acceptable
Jun 15Calculating The Intrinsic Value Of Balchem Corporation (NASDAQ:BCPC)
Jun 10Here's Why We Think Balchem (NASDAQ:BCPC) Is Well Worth Watching
May 26Balchem: A Tale Of Two Businesses
May 10Balchem Corporation's (NASDAQ:BCPC) Popularity With Investors Is Clear
Mar 21Is Balchem Corporation (NASDAQ:BCPC) Expensive For A Reason? A Look At Its Intrinsic Value
Mar 05Balchem: Potential Turnaround Is In The Price
Feb 21These 4 Measures Indicate That Balchem (NASDAQ:BCPC) Is Using Debt Reasonably Well
Feb 18Returns On Capital At Balchem (NASDAQ:BCPC) Have Stalled
Jan 03Balchem Corporation's (NASDAQ:BCPC) P/E Is On The Mark
Dec 19Estimating The Fair Value Of Balchem Corporation (NASDAQ:BCPC)
Nov 20Balchem (NASDAQ:BCPC) Has A Pretty Healthy Balance Sheet
Oct 19The Returns At Balchem (NASDAQ:BCPC) Aren't Growing
Sep 09A Look At The Intrinsic Value Of Balchem Corporation (NASDAQ:BCPC)
Aug 22Is Balchem (NASDAQ:BCPC) A Risky Investment?
Jul 19Some Investors May Be Worried About Balchem's (NASDAQ:BCPC) Returns On Capital
May 28Calculating The Fair Value Of Balchem Corporation (NASDAQ:BCPC)
May 12Do Balchem's (NASDAQ:BCPC) Earnings Warrant Your Attention?
Apr 12We Think Balchem (NASDAQ:BCPC) Can Stay On Top Of Its Debt
Mar 14Balchem (NASDAQ:BCPC) Hasn't Managed To Accelerate Its Returns
Jan 11Here's Why We Think Balchem (NASDAQ:BCPC) Is Well Worth Watching
Dec 29Is Balchem (NASDAQ:BCPC) A Risky Investment?
Dec 13Balchem Corporation (NASDAQ:BCPC) Shares Could Be 26% Above Their Intrinsic Value Estimate
Nov 29Here's What To Make Of Balchem's (NASDAQ:BCPC) Decelerating Rates Of Return
Sep 20Balchem: Acquisitions And Cost Pressures Draw Attention
Sep 12Balchem (NASDAQ:BCPC) Seems To Use Debt Rather Sparingly
Sep 05Balchem to acquire Cardinal Associates or Bergstrom Nutrition
Aug 30Is Balchem Corporation (NASDAQ:BCPC) Worth US$138 Based On Its Intrinsic Value?
Aug 22Should You Be Adding Balchem (NASDAQ:BCPC) To Your Watchlist Today?
Aug 08Balchem Q2 2022 Earnings Preview
Jul 28Balchem: On The M&A Road Again
Jun 28Balchem: A New Growth Stage Is Just Beginning
Jun 02Slowing Rates Of Return At Balchem (NASDAQ:BCPC) Leave Little Room For Excitement
May 30Balchem Corporation's (NASDAQ:BCPC) Intrinsic Value Is Potentially 17% Below Its Share Price
May 18Does Balchem (NASDAQ:BCPC) Deserve A Spot On Your Watchlist?
May 02Does Balchem (NASDAQ:BCPC) Have A Healthy Balance Sheet?
Mar 28Balchem (NASDAQ:BCPC) Hasn't Managed To Accelerate Its Returns
Feb 26Rendement voor aandeelhouders
| BCPC | US Chemicals | US Markt | |
|---|---|---|---|
| 7D | 0.4% | -2.4% | -1.6% |
| 1Y | 41.9% | 14.8% | 30.8% |
Rendement versus industrie: BCPC exceeded the US Chemicals industry which returned 14.8% over the past year.
Rendement versus markt: BCPC exceeded the US Market which returned 30.8% over the past year.
Prijsvolatiliteit
| BCPC volatility | |
|---|---|
| BCPC Average Weekly Movement | 3.4% |
| Chemicals Industry Average Movement | 4.9% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 14.9% |
| 10% least volatile stocks in US Market | 2.9% |
Stabiele aandelenkoers: BCPC has not had significant price volatility in the past 3 months compared to the US market.
Volatiliteit in de loop van de tijd: BCPC's weekly volatility (3%) has been stable over the past year.
Over het bedrijf
| Opgericht | Werknemers | CEO | Website |
|---|---|---|---|
| 1967 | 1,300 | Ted Harris | www.balchem.com |
Balchem Corporation ontwikkelt, produceert en verkoopt hoogwaardige ingrediënten en producten voor de voedings-, voedsel-, farmaceutische, diergezondheids-, sterilisatie-, plantenvoeding- en industriële markten wereldwijd. Het bedrijf is actief in drie segmenten: Humane Voeding en Gezondheid, Diervoeding en Gezondheid, en Specialty Products. Het segment Humane Voeding & Gezondheid levert ingrediënten voor de voedingsmiddelen- en drankenindustrie.
Balchem Corporation Samenvatting
| BCPC fundamentele statistieken | |
|---|---|
| Marktkapitalisatie | US$5.57b |
| Inkomsten(TTM) | US$121.54m |
| Inkomsten(TTM) | US$942.38m |
45.9x
Koers/Winstverhouding5.9x
P/S-verhoudingIs BCPC overgewaardeerd?
Zie Reële waarde en waarderingsanalyseInkomsten en omzet
| BCPC resultatenrekening (TTM) | |
|---|---|
| Inkomsten | US$942.38m |
| Kosten van inkomsten | US$617.52m |
| Brutowinst | US$324.86m |
| Overige uitgaven | US$203.32m |
| Inkomsten | US$121.54m |
Laatst gerapporteerde inkomsten
Sep 30, 2024
Volgende inkomensdatum
n.v.t.
| Winst per aandeel (EPS) | 3.74 |
| Brutomarge | 34.47% |
| Nettowinstmarge | 12.90% |
| Schuld/Eigen Vermogen Verhouding | 19.3% |
Hoe presteerde BCPC op de lange termijn?
Bekijk historische prestaties en vergelijking